Ocular rosacea happens when the eye develops inflammation. It causes the eyes to burn, itch, and become red. Individuals who have rosacea of the skin tend to get ocular rosacea. When an individual ...

Tarsus Pharmaceuticals, Inc. has announced plans to advance TP-04, an investigational ophthalmic gel formulation of lotilaner, for the treatment of Ocular Rosacea, a significant but currently ...

Oppenheimer updated its outlook on Tarsus Pharmaceuticals (NASDAQ:TARS), a $1.8 billion market cap biotechnology company, increasing the price target to $72.00 from the previous $65.00 while ...

Advancing TP-04 (lotilaner ophthalmic gel) for the potential treatment of Ocular Rosacea, another large, underserved eye disease with no FDA-approved therapy; Initiation of Phase 2 study planned ...

Rosacea can also affect your eyes. This is known as ocular rosacea, and it can produce symptoms similar to eye allergies. Topical ophthalmic eye drops can reduce red eyelids, pink eye, itching ...

I finally talked to a dermatologist in 2023, when I was diagnosed with ocular rosacea, which causes chronic inflammation of the skin and eyes. Since then I have incorporated anti-inflammatory ...

Recent studies support associations between rosacea and dyslipidemia, gastrointestinal issues, and depression, which “seem to ...

Moreover, Tarsus is extending its reach into ocular rosacea, a condition with no FDA-approved treatments, by advancing TP-04 into a Phase 2 study. The potential for TP-04 to address a significant ...

Advancing TP-04 (lotilaner ophthalmic gel) for the potential treatment of Ocular Rosacea, another large, underserved eye disease with no FDA-approved therapy; Initiation of Phase 2 study planned ...

Tarsus Pharmaceuticals' lotilaner shows strong market performance for Demodex blepharitis, but cautious investment due to ...